Pharmacogenomics: Identification of New Drug Targets
Huntington Disease l: Introduction
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 17, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
1Unidad de Investigación, Hospital General Universitario Dr. Balmis, ISABIAL, 03010 Alicante, Spain.
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HTT gene. Research focuses on understanding the genetic basis and developing targeted therapies for this condition.
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: